Cerebral small vessel disease (CSVD) is a slowly progress disease, often accompanied by stroke, and result in dementia, depression, cognitive impairment, etc. It had already known that calcium and phosphorus metabolism (CPM) disorders were associated with vascular related adverse events. Serum Ca, P, Ca×P are the most commonly used indicators of CPM in clinical. The risk factors of CSVD and the relationship of serum Ca, P, Ca×P and CSVD in stroke patients who do not have CPM disorders are still obscure. We enrolled 488 CSVD patients in a cohort from a consecutive hospital-based stroke registry, and further subgrouped them into lacunes, white matter hyperintensities (WMHs), cerebral microbleeds (CMBs), and matched them to 140 stroke patients without CSVD as controls. CSVD patients had higher levels of serum Ca, P, Ca×P. We developed 2 predictive models and nomograms (incorporating age, hypertension, P or Ca×P, respectively) for CSVD patients. The prediction and calibration power were good. Area under the curve (AUC) was 0.855, 0.851, respectively. P value of Hosmer-Lemeshow goodness of t (H-L) test was 0.689, 0.698, respectively. P and Ca×P were positive correlated with CSVD, with OR 3720.401 (646.665-21404.249), 1.294 (1.222-1.370), respectively. We further validated the models in lacunes, WMHs, and CMBs, and found models were still valid in these 3 subtypes. In summary, a high serum P or Ca×P are associated with an increased risk of CSVD in stroke patients who without CPM disorders.